U.S. Court Overturns Ranbaxy's Bid to Block Rival Generics

A U.S. court has denied a request by India's Ranbaxy Laboratories to stop competitors from launching generic copies of AstraZeneca's heartburn pill Nexium and Roche's antiviral, Valcyte.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news